September 25, 2023 Southlake, TX, Sept. 25, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Company CEO, Andrew Simpson, will present at Maxim Group’s Virtual […]
Category Archives: News
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
September 21, 2023 Southlake, TX, Sept. 21, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced it has executed definitive agreements with the Icahn School of Medicine at Mount […]
HeartSciences Reports First Quarter Fiscal 2024 Financial Results
September 14, 2023 Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the first quarter […]
HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
September 12, 2023 Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson, will participate in a fireside […]
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 – USA in the Global Health & Pharma Excellence Awards
September 11, 2023 Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been named Electrocardiography Advancement Specialists of the Year 2023 – […]
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
September 7, 2023 Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has extended its distribution channel through a new distribution […]
HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
August 31, 2023 Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has signed a distribution agreement with FJ Medical, Denmark. […]
HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation
August 24, 2023 Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces that its MyoVista® wavECGTM has been selected by PanaceaFlo Ltd to be used […]
EXCLUSIVE: HeartSciences Announces Expansion of Artificial Intelligence Patent Portfolio
http://EXCLUSIVE: HeartSciences Announces Expansion of Artificial Intelligence Patent Portfolio — TradingView News Aug 17, 202307:36 CDT HSCS−2.60% Heart Test Laboratories Inc d/b/a HeartSciences HSCS has been issued a notice of patent allowance from the European Patent Office. To date, HeartSciences has been granted or allowed 41 patents, including nine in the U.S. Issued international patents are across key […]
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
August 17, 2023 European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart […]